Calciphylaxis: An important imitator of cutaneous vasculitis

Arthritis Care and Research

Volumn 57, Issue 3, 2007, Pages 533-537

  Jacobs Kosmin, Dana ^a,c   DeHoratius, Raphael J ^b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Einstein Arthritis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CALCINOSIS; CASE REPORT; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; HUMAN; LEG ULCER; MALE; SKIN BLOOD FLOW; SYNDROME DELINEATION; VASCULITIS;

ABDOMEN; ADULT; CALCIPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EDEMA; FATAL OUTCOME; HUMANS; LEG ULCER; MALE; SKIN DISEASES, VASCULAR; VASCULITIS;

EID: 34247595464     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.22616     Document Type: Article

References (31)

1. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002;15:172-86.
2. Janigan DT, Hirsch DJ, Klassen GA, MacDonald AS. Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure. Am J Kidney Dis 2000;35:588-97.
3. Winkelmann RK, Keating FR Jr. Cutaneous vascular calcification, gangrene and hyperparathyroidism [review]. Br J Dermatol 1970;83:263-8.
4. Barri YM, Graves GS, Knochel JP. Calciphylaxis in a patient with Crohn's disease in the absence of end-stage renal disease. Am J Kidney Dis 1997;29:773-6.
5. Goyal S, Huhn KM, Provost TT. Calciphylaxis in a patient without renal failure or elevated parathyroid hormone: possible aetiological role of chemotherapy. Br J Dermatol 2000;143:1087-90.
6. Mastruserio DN, Nguyen EQ, Nielsen T, Hessel A, Pellegrini AE. Calciphylaxis associated with metastatic breast carcinoma. J Am Acad Dermatol 1999;41:295-8.
7. Fader DJ, Kang S. Calciphylaxis without renal failure [letter]. Arch Dermatol 1996;132:837-8.
8. Riegert-Johnson DL, Kaur JS, Pfeifer EA. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K Mayo Clin Proc 2001;76:749-52.
9. Llach F. The evolving pattern of calciphylaxis: therapeutic considerations. Nephrol Dial Transplant 2001;16:448-51.
10. Mathur RV, Shortland JR, El Nahas AM. Calciphylaxis with facial involvement. Nephrol Dial Transplant 2001;16:2256-7.
11. Khafif RA, DeLima C, Silverberg A, Frankel R. Calciphylaxis and systemic calcinosis: collective review [published erratum appears in Arch Intern Med 1990;150:2592]. Arch Intern Med 1990;150:956-9.
12. Fischer AH, Morris DJ. Pathogenesis of calciphylaxis: study of three cases with literature review [review]. Hum Pathol 1995;26:1055-64.
13. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002;61:2210-7.
14. Essary LR, Wick MR. Cutaneous calciphylaxis: an underrecognized clinicopathologic entity. Am J Clin Pathol 2000;113:280-7.
15. Au S, Crawford RI. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. J Am Acad Dermatol 2002;47:53-7.
16. Ledbetter LS, Khoshnevis MR, Hsu S. Calciphylaxis. Cutis 2000;66:49-51.
17. Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL. A case control study of proximal calciphylaxis. Am J Kidney Dis 1998;32:376-83.
18. Handa SP, Sohi PS. Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients [letter]. Am J Kidney Dis 1997;29:812.
19. Melikoglu M, Apaydin S, Hamuryudan V, Yurdakul S, Uygun N, Aki H, et al. Calciphylaxis: a condition mimicking necrotizing vasculitis. Clin Rheumatol 1996;15:489-500.
20. Lue C, Boulware DW, Sanders PW, Omura EF, Ball EV. Calciphylaxis mimicking skin lesions of connective tissue diseases. South Med J 1996;89:1099-100.
21. Sakr SH, Russel EB, Jasin HE. Systemic lupus erythematosus and calciphylaxis. J Rheumatol 2004;31:1851-3.
22. Budisavljevic MN, Cheek D, Ploth DW. Calciphylaxis in chronic renal failure [review]. J Am Soc Nephrol 1996;7:978-82.
23. Hafner J, Keusch G, Wahl C, Sauter B, Hurlimann A, von Weizsacker F, et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol 1995;33:954-62.
24. Chan YL, Mahoney JF, Turner JJ, Posen S. The vascular lesions associated with skin necrosis in renal disease. Br J Dermatol 1983;109:85-95.
25. Don BR, Chin AI. A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol 2003;59:463-70.
26. Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004;43:1104-8.
27. Guerra G, Shah RC, Ross EA. Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant 2005;20:1260-2.
28. Brucculeri M, Cheigh J, Bauer G, Serur D. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 2005;18:431-4.
29. Basile C, Montanaro A, Masi M, Pati G, De Maio P, Gismondi A. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol 2002;15:676-80.
30. Podymow T, Wherrett C, Burns KD. Hyperbaric oxygen in the treatment of calciphylaxis: a case series. Nephrol Dial Transplant 2001;16:2176-80.
31. Monney P, Nguyen QV, Perroud H, Descombes E. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 2004;19:2130-2.